what is glp 1 receptor agonist GLP-1 Agonists What do GLP 1 receptor
Description
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
Some of the beneficial effects seen in their data, particularly in neuropsychiatric and substance abuse disorders, are supported by other studies
Any steroid taper must be done gradually under rheumatological supervision
10.1016/j.molmet.2020.101102 59 NeelandI
A.Moriguchi-JeckelC
